Status:
COMPLETED
The Combination of PECS II Block and Parasternal Block for Radical Mastectomy
Lead Sponsor:
San Salvatore Hospital of L'Aquila
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The combination of PECS II and parasternal Block provides analgesia after radical mastectomy
Detailed Description
The cambionation of PECS II block and parasternal block
Eligibility Criteria
Inclusion
- ASA status patients:1,2 and 3
- patients undergoing to radical mastectomy with axillary dissection and breast-implant reconstruction
Exclusion
- patients with allergy to local anesthetics
- ASA status patients: 4
- breast anatomy abnormalities
- neurological diseases
- septic conditions
- coagulopathies
- drug abuse history
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2019
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03754816
Start Date
December 1 2018
End Date
April 12 2019
Last Update
April 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Salvatore Academic Hospital
Coppito, L'Aquila, Italy, 67100